Weight Loss and Obesity Treatment In addition to their role in managing type 2 diabetes, GLP-1 agonists have gained significant attention for their potential in promoting weight loss and treating obesity
The common side effects reported with GLP-1 weight-loss injections such as Ozempic include: nausea vomiting persistent stomach discomfort constipation diarrhoea bloating reflux-like symptoms fatigue dizziness reduced desire to eat to the point of food aversion For many people, eating becomes uncomfortable rather than supportive
Current areas of scientific investigation include ghrelin receptor binding and selectivity studies, growth hormone secretagogue signaling analysis, intracellular calcium mobilization research, endocrine signaling pathway investigation, receptor activation kinetics studies, and peptide signaling network analysis
On day 7 seedlings were transferred to fresh growth medium, and then some of the plates were supplemented with AITC to a final concentration of 1 mM whereas others remained non-treated (control)
Affiliate relationships do not influence editorial content or product evaluation
Nature 581 , 434443 (2020)